Related references
Note: Only part of the references are listed.Epilepsy treatment in adults and adolescents: Expert opinion, 2016
Jerry J. Shih et al.
EPILEPSY & BEHAVIOR (2017)
Tolerability of new antiepileptic drugs: a network meta-analysis
Gaetano Zaccara et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Levetiracetam Pharmacokinetics in Japanese Subjects with Renal Impairment
Junichi Yamamoto et al.
CLINICAL DRUG INVESTIGATION (2014)
Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs
Gaetano Zaccara et al.
EPILEPTIC DISORDERS (2014)
Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy
Dong Wook Kim et al.
EPILEPSIA (2013)
Intravenous Levetiracetam as first-line treatment of status epilepticus in the elderly
J. Fattouch et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Pancytopenia Associated with Levetiracetam Treatment
Massimo Gallerani et al.
CLINICAL DRUG INVESTIGATION (2009)
Clinically relevant drug interactions with antiepileptic drugs
E Perucca
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Use of levetiracetam in treating epilepsy associated with other medical conditions
C Di Bonaventura et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs:: A pooled analysis of data from randomized clinical trials
BE Gidal et al.
EPILEPSY RESEARCH (2005)
Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies
MS Benedetti
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2000)
Share Paper
